
Category: immuno-oncology
June 16, 2023 / Clin Cancer Res
Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer
Purpose: Cemiplimab is approved for the treatment of locally advanced basal cell carcinomas (BCCs), however with mitigated results. We sought to interrogate the cellular and molecular transcriptional reprogramming underlying BCC…
October 17, 2022 / Clin Transl Med
The prognostic value and molecular properties of tertiary lymphoid structures in oesophageal squamous cell carcinoma
September 12, 2022 / Brain Pathol
Differential expression of checkpoint markers in the normoxic and hypoxic microenvironment of glioblastomas
July 13, 2022 / Ann Surg Oncol
Multidimensional Immunophenotyping of Intraductal Papillary Mucinous Neoplasms Reveals Novel T Cell and Macrophage Signature
June 27, 2022 / Theranostics